Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with ...

rummy fours Hengrui's first quarter report: Net profit increased by more than 10% year-on-year! 24 new products have been listed Roche's satralizumab significantly reduces relapse risk in Phase 3 ...